Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0781
    -0.0013 (-0.12%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2620
    -0.0002 (-0.02%)
     
  • USD/JPY

    151.3880
    +0.0160 (+0.01%)
     
  • Bitcoin USD

    70,407.77
    +109.81 (+0.16%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Trade Alert: Peter Kamin At Kewaunee Scientific Corporation (NASDAQ:KEQU), Has Just Spent US$421k Buying 22% More Shares

Investors who take an interest in Kewaunee Scientific Corporation (NASDAQ:KEQU) should definitely note that insider Peter Kamin recently paid US$14.05 per share to buy US$421k worth of the stock. That's a very decent purchase to our minds and it grew their holding by a solid 22%.

Check out our latest analysis for Kewaunee Scientific

Kewaunee Scientific Insider Transactions Over The Last Year

In fact, the recent purchase by Peter Kamin was the biggest purchase of Kewaunee Scientific shares made by an insider individual in the last twelve months, according to our records. That implies that an insider found the current price of US$14.24 per share to be enticing. That means they have been optimistic about the company in the past, though they may have changed their mind. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the Kewaunee Scientific insider decided to buy shares at close to current prices. The only individual insider to buy over the last year was Peter Kamin.

Peter Kamin bought a total of 38.75k shares over the year at an average price of US$13.78. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

Kewaunee Scientific is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Does Kewaunee Scientific Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. Insiders own 22% of Kewaunee Scientific shares, worth about US$8.9m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

So What Does This Data Suggest About Kewaunee Scientific Insiders?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Insiders likely see value in Kewaunee Scientific shares, given these transactions (along with notable insider ownership of the company). While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example, Kewaunee Scientific has 2 warning signs (and 1 which can't be ignored) we think you should know about.

Of course Kewaunee Scientific may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Advertisement